GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » E10

Betta Pharmaceuticals Co (SZSE:300558) E10 : ¥0.88 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Betta Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.450. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.88 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-06), Betta Pharmaceuticals Co's current stock price is ¥54.52. Betta Pharmaceuticals Co's E10 for the quarter that ended in Sep. 2024 was ¥0.88. Betta Pharmaceuticals Co's Shiller PE Ratio of today is 61.95.

During the past 13 years, the highest Shiller PE Ratio of Betta Pharmaceuticals Co was 65.63. The lowest was 37.18. And the median was 55.66.


Betta Pharmaceuticals Co E10 Historical Data

The historical data trend for Betta Pharmaceuticals Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co E10 Chart

Betta Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Betta Pharmaceuticals Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.85 0.88

Competitive Comparison of Betta Pharmaceuticals Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Betta Pharmaceuticals Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's Shiller PE Ratio falls into.


;
;

Betta Pharmaceuticals Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Betta Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.45/115.7848*115.7848
=0.450

Current CPI (Sep. 2024) = 115.7848.

Betta Pharmaceuticals Co Quarterly Data

per share eps CPI Adj_EPS
201212 0.000 95.237 0.000
201312 0.390 97.624 0.463
201412 0.000 99.000 0.000
201509 0.000 100.500 0.000
201512 0.150 100.600 0.173
201603 0.290 102.200 0.329
201606 0.300 101.400 0.343
201609 0.270 102.400 0.305
201612 0.150 102.600 0.169
201703 0.190 103.200 0.213
201706 0.150 103.100 0.168
201709 0.170 104.100 0.189
201712 0.130 104.500 0.144
201803 0.110 105.300 0.121
201806 0.060 104.900 0.066
201809 0.200 106.600 0.217
201812 0.050 106.500 0.054
201903 0.130 107.700 0.140
201906 0.090 107.700 0.097
201909 0.280 109.800 0.295
201912 0.070 111.200 0.073
202003 0.320 112.300 0.330
202006 0.030 110.400 0.031
202009 0.910 111.700 0.943
202012 0.220 111.500 0.228
202103 0.350 112.662 0.360
202106 0.160 111.769 0.166
202109 0.300 112.215 0.310
202112 0.080 113.108 0.082
202203 0.200 114.335 0.203
202206 0.030 114.558 0.030
202209 0.020 115.339 0.020
202212 0.100 115.116 0.101
202303 0.120 115.116 0.121
202306 0.230 114.558 0.232
202309 0.370 115.339 0.371
202312 0.100 114.781 0.101
202403 0.230 115.227 0.231
202406 0.310 114.781 0.313
202409 0.450 115.785 0.450

Add all the adjusted EPS together and divide 10 will get our e10.


Betta Pharmaceuticals Co  (SZSE:300558) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Betta Pharmaceuticals Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=54.52/0.88
=61.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Betta Pharmaceuticals Co was 65.63. The lowest was 37.18. And the median was 55.66.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Betta Pharmaceuticals Co E10 Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Betta Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 355, Xingzhong Road, Economic and Technological Development Zone, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311100
Betta Pharmaceuticals Co Ltd is a pharmaceutical enterprise that focuses on the research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates in China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co Headlines

No Headlines